Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.

MLA

Palanca-Ballester, Cora, et al. “Translation of a Tissue Epigenetic Signature to Circulating Free DNA Suggests BCAT1 as a Potential Noninvasive Diagnostic Biomarker for Lung Cancer.” Clinical Epigenetics, vol. 14, no. 1, Sept. 2022, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s13148-022-01334-3.

APA

Palanca-Ballester, C., Hervas, D., Villalba, M., Valdes-Sanchez, T., Garcia, D., Alcoriza-Balaguer, M. I., Benet, M., Martinez-Tomas, R., Briones-Gomez, A., Galbis-Caravajal, J., Calvo, A., Juan, O., Lahoz, A., Cases, E., & Sandoval, J. (2022). Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer. Clinical Epigenetics, 14(1), 1–6. https://doi.org/10.1186/s13148-022-01334-3

Chicago

Palanca-Ballester, Cora, David Hervas, Maria Villalba, Teresa Valdes-Sanchez, Diana Garcia, Maria Isabel Alcoriza-Balaguer, Marta Benet, et al. 2022. “Translation of a Tissue Epigenetic Signature to Circulating Free DNA Suggests BCAT1 as a Potential Noninvasive Diagnostic Biomarker for Lung Cancer.” Clinical Epigenetics 14 (1): 1–6. doi:10.1186/s13148-022-01334-3.